A GLP-grade non-replicative Leishmaniamajor parasite protects hamsters from lethal leishmaniasis infection, setting the stage for human clinical trials and the first potential vaccine for leishmaniasis.
When a research question can’t be answered using the tools available, bioengineer Kiana Aran makes new tools. Recently, she developed a new type of brain-on-a-chip to answer questions about the blood brain barrier.
Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.